We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
GLP-1 receptor agonists: fighting obesity with an eye to cardiovascular risk.
- Authors
Liuzzo, Giovanna; Galiuto, Leonarda
- Abstract
The article presents the discussion on once-weekly Semaglutide in adults with overweight or obesity. Topics include participants receiving semaglutide haing a greater improvement in cardiometabolic risk factors such as systolic and diastolic blood pressure and glycated haemoglobin; and Glucagon-like peptide-1 playing a role in regulating eating behaviour by reducing appetite and food consumption acting on the hypothalamus, limbic reward system, and cortex.
- Subjects
OBESITY; BLOOD pressure; HEMOGLOBINS; GLUCAGON-like peptide 1; FOOD consumption
- Publication
European Heart Journal, 2021, Vol 42, Issue 17, p1652
- ISSN
0195-668X
- Publication type
Article
- DOI
10.1093/eurheartj/ehab175